Clinical Practice Guidelines, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 3.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/cqf-recommendations/ and changes regularly. See the Directory of published versions
| Page standards status: Informative |
{
"resourceType" : "PlanDefinition",
"id" : "ckd-hypertension-options-pd",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition"🔗 ,
"http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-computableplandefinition"
]
},
"language" : "en",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <table class=\"narrative-table\">\n <tbody>\n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\"><a name=\"metadata\"> </a>Metadata</th>\n\n\n</tr>\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Version</th>\n\n\n\n<td class=\"content-container\">3.0.0-ballot</td>\n\n\n</tr>\n\n\n\n\n\n\n\n \n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Identifier</th>\n\n\n\n<td class=\"content-container\">urn:oid:2.16.840.1.113883.4.642.40.48.34.39</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Experimental</th>\n\n\n\n<td class=\"content-container\">true</td>\n\n\n</tr>\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Use Context</th>\n\n\n\n<td class=\"content-container\">\n Clinical Focus\n\n = \n Chronic kidney disease (disorder)\n\n\n</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Jurisdiction</th>\n\n\n\n<td class=\"content-container\">\n World\n\n\n</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Topic</th>\n\n\n\n<td class=\"content-container\">\n Treatment\n\n\n</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Steward (Publisher)</th>\n\n\n\n<td class=\"content-container\">HL7 International / Clinical Decision Support</td>\n\n\n</tr>\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Steward Contact</th>\n\n\n\n<td class=\"content-container\">HL7 International / Clinical Decision Support</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Type</th>\n\n\n\n<td class=\"content-container\">\n ECA Rule\n\n\n</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Action</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">initial-antihypertensive-therapy</td>\n\n\n</tr>\n\n\n \n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Strength of Recommendation</th>\n\n\n\n<td class=\"content-container\">\n Strong\n\n\n</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Initial antihypertensive therapy in CKD with albuminuria</td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\">For a patient with chronic kidney disease, hypertension, and albuminuria, start antihypertensive therapy, choosing one of the following options.</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n <th scope=\"row\" class=\"row-header\">Condition</th>\n <td class=\"content-container\">\n <em>Kind</em>: Applicability\n \n <br/>\n <em>Logic Definition</em>: <code>Has CKD with hypertension and albuminuria</code>\n \n \n </td>\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Grouping Behavior</th>\n\n\n\n<td class=\"content-container\">Logical Group</td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Selection Behavior</th>\n\n\n\n<td class=\"content-container\">At Most One</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action (Parent Action ID: initial-antihypertensive-therapy)</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">ace-inhibitor</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Start an ACE inhibitor</td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\">Preferred option. Excluded by its applicability condition, not by its preference, for a patient with a history of ACE inhibitor angioedema.</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n <th scope=\"row\" class=\"row-header\">Condition</th>\n <td class=\"content-container\">\n <em>Kind</em>: Applicability\n \n <br/>\n <em>Logic Definition</em>: <code>No history of ACE inhibitor angioedema</code>\n \n \n </td>\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Definition</th>\n\n\n\n<td class=\"content-container\"><a href=\"ActivityDefinition-ckd-hypertension-ace-inhibitor-ad.html\">CKDHypertensionACEInhibitor</a></td>\n\n\n</tr>\n\n\n\n\n\n\n\n \n \n \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">ace-inhibitor</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Start an ACE inhibitor</td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\">Preferred option. Excluded by its applicability condition, not by its preference, for a patient with a history of ACE inhibitor angioedema.</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n <th scope=\"row\" class=\"row-header\">Condition</th>\n <td class=\"content-container\">\n <em>Kind</em>: Applicability\n \n <br/>\n <em>Logic Definition</em>: <code>No history of ACE inhibitor angioedema</code>\n \n \n </td>\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Definition</th>\n\n\n\n<td class=\"content-container\"><a href=\"ActivityDefinition-ckd-hypertension-ace-inhibitor-ad.html\">CKDHypertensionACEInhibitor</a></td>\n\n\n</tr>\n\n\n\n\n\n\n\n \n \n \n \n \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action (Parent Action ID: initial-antihypertensive-therapy)</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">arb</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Start an angiotensin receptor blocker</td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\">Recommended alternative, for example when an ACE inhibitor is not tolerated.</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Definition</th>\n\n\n\n<td class=\"content-container\"><a href=\"ActivityDefinition-ckd-hypertension-arb-ad.html\">CKDHypertensionARB</a></td>\n\n\n</tr>\n\n\n\n\n\n\n\n \n \n \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">arb</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Start an angiotensin receptor blocker</td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\">Recommended alternative, for example when an ACE inhibitor is not tolerated.</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Definition</th>\n\n\n\n<td class=\"content-container\"><a href=\"ActivityDefinition-ckd-hypertension-arb-ad.html\">CKDHypertensionARB</a></td>\n\n\n</tr>\n\n\n\n\n\n\n\n \n \n \n \n \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action (Parent Action ID: initial-antihypertensive-therapy)</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">calcium-channel-blocker</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Start a dihydropyridine calcium channel blocker</td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\">Allowable, but not favored as initial monotherapy for this patient among the available alternatives. This is not a recommendation against the activity.</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Definition</th>\n\n\n\n<td class=\"content-container\"><a href=\"ActivityDefinition-ckd-hypertension-ccb-ad.html\">CKDHypertensionCCB</a></td>\n\n\n</tr>\n\n\n\n\n\n\n\n \n \n \n<tr>\n\n\n<th colspan=\"2\" scope=\"row\" class=\"row-header\">PlanDefinition Sub-Action</th>\n\n\n</tr>\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Id</th>\n\n\n\n<td class=\"content-container\">calcium-channel-blocker</td>\n\n\n</tr>\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Title</th>\n\n\n\n<td class=\"content-container\">Start a dihydropyridine calcium channel blocker</td>\n\n\n</tr>\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Description</th>\n\n\n\n<td class=\"content-container\">Allowable, but not favored as initial monotherapy for this patient among the available alternatives. This is not a recommendation against the activity.</td>\n\n\n</tr>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n<tr>\n\n\n<th scope=\"row\" class=\"row-header\">Definition</th>\n\n\n\n<td class=\"content-container\"><a href=\"ActivityDefinition-ckd-hypertension-ccb-ad.html\">CKDHypertensionCCB</a></td>\n\n\n</tr>\n\n\n\n\n\n\n\n \n \n\n\n\n\n\n\n\n\n<tr>\n <th colspan=\"2\" scope=\"row\" class=\"row-header\">Generated using version 0.5.6 of the sample-content-ig Liquid templates</th>\n</tr>\n\n </tbody>\n </table>\n</div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode" : "shareable"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode" : "computable"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability",
"valueCode" : "publishable"
}
],
"url" : "http://hl7.org/fhir/uv/cpg/PlanDefinition/ckd-hypertension-options-pd",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.4.642.40.48.34.39"
}
],
"version" : "3.0.0-ballot",
"name" : "CKDHypertensionTherapyOptions",
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/plan-definition-type",
"code" : "eca-rule",
"display" : "ECA Rule"
}
]
},
"status" : "active",
"experimental" : true,
"date" : "2026-11-20T14:03:30+00:00",
"publisher" : "HL7 International / Clinical Decision Support",
"contact" : [
{
"name" : "HL7 International / Clinical Decision Support",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/dss"
}
]
}
],
"useContext" : [
{
"code" : {
"system" : "http://terminology.hl7.org/CodeSystem/usage-context-type",
"code" : "focus",
"display" : "Clinical Focus"
},
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "709044004",
"display" : "Chronic kidney disease (disorder)"
}
]
}
}
],
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "001",
"display" : "World"
}
]
}
],
"topic" : [
{
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/definition-topic",
"code" : "treatment",
"display" : "Treatment"
}
]
}
],
"action" : [
{
"id" : "initial-antihypertensive-therapy",
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/cqf-strengthOfRecommendation",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/recommendation-strength",
"code" : "strong",
"display" : "Strong"
}
]
}
},
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-directionOfRecommendation",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-recommendation-direction-cs",
"code" : "for",
"display" : "For"
}
]
}
}
],
"title" : "Initial antihypertensive therapy in CKD with albuminuria",
"description" : "For a patient with chronic kidney disease, hypertension, and albuminuria, start antihypertensive therapy, choosing one of the following options.",
"condition" : [
{
"kind" : "applicability",
"expression" : {
"language" : "text/cql",
"expression" : "Has CKD with hypertension and albuminuria"
}
}
],
"groupingBehavior" : "logical-group",
"selectionBehavior" : "at-most-one",
"action" : [
{
"id" : "ace-inhibitor",
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-preferenceBehavior",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-preference-behavior-cs",
"code" : "preferred",
"display" : "Preferred"
}
]
}
}
],
"title" : "Start an ACE inhibitor",
"description" : "Preferred option. Excluded by its applicability condition, not by its preference, for a patient with a history of ACE inhibitor angioedema.",
"condition" : [
{
"kind" : "applicability",
"expression" : {
"language" : "text/cql",
"expression" : "No history of ACE inhibitor angioedema"
}
}
],
"definitionCanonical" : "http://hl7.org/fhir/uv/cpg/ActivityDefinition/ckd-hypertension-ace-inhibitor-ad"
},
{
"id" : "arb",
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-preferenceBehavior",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-preference-behavior-cs",
"code" : "recommended",
"display" : "Recommended"
}
]
}
}
],
"title" : "Start an angiotensin receptor blocker",
"description" : "Recommended alternative, for example when an ACE inhibitor is not tolerated.",
"definitionCanonical" : "http://hl7.org/fhir/uv/cpg/ActivityDefinition/ckd-hypertension-arb-ad"
},
{
"id" : "calcium-channel-blocker",
"extension" : [
{
"url" : "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-preferenceBehavior",
"valueCodeableConcept" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/cpg/CodeSystem/cpg-preference-behavior-cs",
"code" : "not-recommended",
"display" : "Not Recommended"
}
]
}
}
],
"title" : "Start a dihydropyridine calcium channel blocker",
"description" : "Allowable, but not favored as initial monotherapy for this patient among the available alternatives. This is not a recommendation against the activity.",
"definitionCanonical" : "http://hl7.org/fhir/uv/cpg/ActivityDefinition/ckd-hypertension-ccb-ad"
}
]
}
]
}